Molecular determinants of Alzheimer's disease A beta peptide neurotoxicity

被引:8
作者
Cappai, Roberto [1 ]
Barnham, Kevin J. [2 ]
机构
[1] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Pathol, Melbourne, Vic 3010, Australia
[2] Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia
关键词
A beta; Alzheimer's disease; amyloid; metal; neurodegeneration; oligomer; oxidative stress; synapse; tau; toxicity;
D O I
10.2217/14796708.2.4.397
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Alzheimer's disease amyloid precursor protein is sequentially processed to yield the neurotoxic amyloid-beta (A beta) peptide, which is the principal component of the senile plaques in Alzheimer's disease brains. This review will outline the current thinking on how A beta mediates neurotoxicity or neuronal dysfunction. In particular, this article will focus on the key residues that modulate A beta's activity and the cellular pathways and mechanisms involved. It will detail how A beta-metal interactions are a key determinate in Alzheimer's disease pathogenesis.
引用
收藏
页码:397 / 409
页数:13
相关论文
共 128 条
[81]   Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β [J].
Nakagawa, T ;
Zhu, H ;
Morishima, N ;
Li, E ;
Xu, J ;
Yankner, BA ;
Yuan, JY .
NATURE, 2000, 403 (6765) :98-103
[82]   RELATIVE ABUNDANCE OF ALZHEIMER A-BETA AMYLOID PEPTIDE VARIANTS IN ALZHEIMER-DISEASE AND NORMAL AGING [J].
NASLUND, J ;
SCHIERHORN, A ;
HELLMAN, U ;
LANNFELT, L ;
ROSES, AD ;
TJERNBERG, LO ;
SILBERRING, J ;
GANDY, SE ;
WINBLAD, B ;
GREENGARD, P ;
NORDSTEDT, C ;
TERENIUS, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8378-8382
[83]   Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline [J].
Näslund, J ;
Haroutunian, V ;
Mohs, R ;
Davis, KL ;
Davies, P ;
Greengard, P ;
Buxbaum, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (12) :1571-1577
[84]   Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro [J].
Ono, K ;
Hasegawa, K ;
Naiki, H ;
Yamada, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 75 (06) :742-750
[85]   Metalloenzyme-like activity of Alzheimer's disease β-amyloid -: Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2 [J].
Opazo, C ;
Huang, XD ;
Cherny, RA ;
Moir, RD ;
Roher, AE ;
White, AR ;
Cappai, R ;
Masters, CL ;
Tanzi, RE ;
Inestrosa, NC ;
Bush, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40302-40308
[86]   Role of p75 neurotrophin receptor in the neurotoxicity by β-amyloid peptides and synergistic effect of inflammatory cytokines [J].
Perini, G ;
Della-Bianca, V ;
Politi, V ;
Della Valle, G ;
Dal-Pra, I ;
Rossi, F ;
Armato, U .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) :907-918
[87]   In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid β-peptide (1-42)-induced oxidative stress [J].
Perluigi, M ;
Joshi, G ;
Sultana, R ;
Calabrese, V ;
De Marco, C ;
Coccia, R ;
Butterfield, DA .
NEUROSCIENCE, 2006, 138 (04) :1161-1170
[88]   INVITRO AGING OF BETA-AMYLOID PROTEIN CAUSES PEPTIDE AGGREGATION AND NEUROTOXICITY [J].
PIKE, CJ ;
WALENCEWICZ, AJ ;
GLABE, CG ;
COTMAN, CW .
BRAIN RESEARCH, 1991, 563 (1-2) :311-314
[89]  
PIKE CJ, 1993, J NEUROSCI, V13, P1676
[90]   AGGREGATION-RELATED TOXICITY OF SYNTHETIC BETA-AMYLOID PROTEIN IN HIPPOCAMPAL CULTURES [J].
PIKE, CJ ;
WALENCEWICZ, AJ ;
GLABE, CG ;
COTMAN, CW .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 207 (04) :367-368